Displaying items by tag: department of medicine

When UAB employee Jamie Smith collapsed one morning while she was at work, UAB employees from multiple specialties stepped in to help save her life.
Experts at the UAB Cardiovascular Institute and UAB St. Vincent’s say it is never too early or too late for women to begin protecting themselves from heart disease.
With a $2.47 million gift from Novo Nordisk Inc., Live HealthSmart Alabama is applying its holistic health model in Selma, Camden, Demopolis and other underserved communities.
UAB researchers reveal how managing cardiovascular risk factors can mitigate heart failure risk in Black individuals carrying the transthyretin V142I genetic variant.
Injecting infarcted pig hearts with specially bioengineered cells significantly decreased the infarct area and improved heart function, showing possible clinical relevance.
This study highlights how high-volume centers, where operators perform these procedures more frequently, achieve better outcomes, including lower 30-day mortality and reduced complication rates. 
Heart failure is responsible for 13 percent of deaths worldwide, and half of patients die within 5 years. New therapies are needed.
The goal of this project is to reduce health disparities in colonoscopy screening and colorectal cancer outcomes for vulnerable populations in Jefferson County.
Funded by the National Institutes of Health, HEALTHe Birmingham will measure the effects of community revitalization on residents’ health.
The funding will be used in two projects to combat growing syphilis rates in men and women in underserved areas.
By understanding the differences between these illnesses and utilizing convenient health care options, proactive steps can be taken to protect one’s health and support the health care system during this busy season.
One UAB expert says the roles of screenings, warning signs and a healthy lifestyle are all keys to cancer prevention.
Poor nutrition comes with risks such as pre-term birth, gestational diabetes, excess weight gain, hypertensive disorders and potential complications with delivery, among other issues.
AFib is expected to affect 40 million people worldwide and can be fatal if not treated. UAB experts provide tips on symptoms, risk factors and management of this condition.
By showing a critical role for sialylation in the biophysical properties of mucus and mucus transport, the study identifies a possible therapeutic target for the treatment of cystic fibrosis and other muco-obstructive diseases.
Page 1 of 38